Materias dentro de su búsqueda.
Mostrando 138,701 - 138,720 Resultados de 138,720 Para Buscar 'Huamarí~', tiempo de consulta: 2.64s Limitar resultados
  1. 138701
    por Cascella, Michele
    Publicado 2012
    “…In the second chapter the details of the prompt photon theory are reviewed together with a short summary of the previous experimental measurements. …”
    Enlace del recurso
    Measurement of the associated production of direct photons and jets with the ATLAS experiment at LHC
  2. 138702
    “…Conclusions: This paired EVs and ECs miRNAome analyses provided a comprehensive cross-sectional and longitudinal summary of the host exmiRNA responses to SIV infection and the impact of THC, cART, or THC and cART together on the miRNAome during SIV infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ(9)-THC)
  3. 138703
    “…STUDY QUESTION: Is the total number of oocytes retrieved with dual ovarian stimulation in the same cycle (duostim) higher than with two consecutive antagonist cycles in poor responders? SUMMARY ANSWER: Based on the number of total and mature oocytes retrieved in women with poor ovarian response (POR), there is no benefit of duostim versus two consecutive antagonist cycles. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF
  4. 138704
    “…Application of the findings of this review would depend on trial setting, population, disease area, data collection and follow-up procedures. PLAIN LANGUAGE SUMMARY: METHODS THAT MIGHT HELP TO KEEP PEOPLE IN RANDOMISED TRIALS: Background Most trials follow people up to collect data through personal contact after they have been recruited. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Strategies to improve retention in randomised trials
  5. 138705
    por Goldenberg, Larry
    Publicado 2014
    “…These studies would support multiple previous publications that suggest that men with normal T levels actually have longer life expectancies than hypogonadal men and that both low and high T levels have negative physiologic impact on male health. In summary, “expert views” from all walks of life (endocrinologists, epidemiologists, gerontologists, public health experts and urologists; lay press and regulatory agencies; pharmaceutical and film industry) is resulting in a cacophony of opinions creating much confusion and detriment to patients and physicians alike. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    AB19. Testosterone replacement therapy: how safe is it?
  6. 138706
    “…There are insufficient studies to estimate sensitivity of tests beyond 35 days post‐symptom onset. Summary specificities (provided in 35 studies) exceeded 98% for all target antibodies with confidence intervals no more than 2 percentage points wide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antibody tests for identification of current and past infection with SARS‐CoV‐2
  7. 138707
    “…We carried out statistical analysis using Review Manager software and set out the main findings of the review in “Summary of findings” tables. MAIN RESULTS: This review summarises findings from a total of 42 studies (48 papers) including 35,017 children. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of interventions to manage acute malnutrition in children under 5 years of age in low‐ and middle‐income countries: A systematic review
  8. 138708
    “…We synthesized data for each vaccine separately and presented summary effect estimates with 95% confidence intervals (CIs).  …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of COVID‐19 vaccines
  9. 138709
    “…The PK/PD index T >MIC fit the treatment efficacy data well (R(2) 0.66-0.91). Summary statistics for PK/PD analyses are shown in Figure. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2552. Comparative Pharmacodynamic Evaluation of Commonly Utilized, Oral, 1(st) - 3(rd) Generation Cephalosporins against S. aureus and E. coli in the Mouse Thigh Infection Model
  10. 138710
    “…Most trials excluded people with G6PD deficiency, and thus there is little reliable evidence from controlled trials of the safety of PQ in single dose or short course. PLAIN LANGUAGE SUMMARY: A SINGLE DOSE OF PRIMAQUINE ADDED TO MALARIA TREATMENT TO PREVENT MALARIA TRANSMISSION: We conducted a review of the effects of adding a single dose (or short course) of primaquine to malaria treatment with the aim of reducing the transmission of malaria. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission
  11. 138711
    “…Most trials excluded people with G6PD deficiency, and thus there is little reliable evidence from controlled trials of the safety of PQ in single dose or short course. PLAIN LANGUAGE SUMMARY: A single dose of primaquine added to malaria treatment to prevent malaria transmission We conducted a review of the effects of adding a single dose (or short course) of primaquine to malaria treatment with the aim of reducing the transmission of malaria. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission
  12. 138712
    “…There is great need for clinical trials of new therapies in children so that they have equal access to emerging treatments and optimal pediatric dosing can be established. KEY SUMMARY POINTS: 1. Rates of new diagnoses in children under 16 years old were increasing most rapidly in Ontario (increased 5.8% per year) and Quebec (increased 2.8% per year). 2. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
  13. 138713
    “…These differences (higher density, and better connectivity) both increase the risk of transmission in the post-COVID networks. In summary, the post-COVID networks either have similar properties as the pre-COVID networks, or had changes which are unlikely to have played a role in reducing MRSA transmission. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    173. Deciphering COVID-19-Associated Effects on Hospital MRSA Transmission and Social Networks
  14. 138714
    “…METHODS: 8,643 organisms were consecutively collected (1/patient) from 74 medical centers located in the US (n=4,544; 33 centers), western EU (W-EU; n=3,330; 28 centers from 10 nations: Belgium, France, Germany, Ireland, Italy, Portugal, Spain, Sweden, Switzerland, and the United Kingdom), and eastern EU (E-EU; n=769; 13 centers from 10 nations: Belarus, Czech Republic, Greece, Hungary, Israel, Poland, Romania, Russia, Slovenia, and Turkey). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    217. Antimicrobial Activity of Dalbavancin against Gram-Positive Bacteria Isolated from Patients Hospitalized with Bacteremia in United States and European Medical Centers: Results from the International Dalbavancin Evaluation of Activity (IDEA) Program (2018-202)
  15. 138715
    por Ildefons Magrans de Abril
    Publicado 2008
    “…This effort, carried out in the context of the CMS Triggerand Data Acquisition project, improved the overall team knowledge on XML technologies, created a pool ofideas and helped to anticipate the main TS requirements and architectural concepts.VISUAL SUMMARY ............................................................................................................................................... …”
    Enlace del recurso
    The CMS Trigger Supervisor: Control and Hardware Monitoring System of the CMS Level-1 Trigger at CERN
  16. 138716
    “…Most common Treatment-Emergent AEs of Grade ≥3 regardless of causality were neutropenia in 51.5%, thrombocytopenia in 50%, anemia in 40%, febrile neutropenia in 26%, leukopenia in 21%, pneumonia in 12%, and sepsis in 7% of patients treated with oral decitabine/cedazuridine (excluding the IV decitabine cycle). Summary/Conclusions: Efficacy and safety from oral decitabine 35 mg/ cedazuridine 100 mg daily for 5 days every 28 days are consistent with clinical data from standard IV decitabine 20 mg/m(2) daily for 5 days. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
  17. 138717
    por Koh, Dow-Mu, Kaste, Sue Creviston, Vinnicombe, Sarah J., Morana, Giovanni, Rossi, Andrea, Herold, Christian J., McLoud, Theresa C., Frey, Kirk A., Gebauer, Bernhard, Roebuck, Derek, Fütterer, Jurgen J., Towbin, Alexander J., Huisman, Thierry A. G., Smets, Anne M. J. B., Morana, Giovanni, Lee, Jeong Min, Chandarana, Hersh, Mayerhoefer, Marius E., Raderer, Markus, Haug, Alexander, Eiber, Matthias, Gebauer, Bernhard, Rockall, Andrea, Sohaib, Aslam, Warbey, Victoria S, Vargas, Hebert Alberto, Koh, Dow-Mu, Heiken, Jay P., Francis, Isaac R., Al-Hawary, Mahmoud M., Kaza, Ravi K., Morana, Giovanni, D’Onofrio, Mirko, Thoeny, Harriet C., King, Ann D., Morana, Giovanni, Piccardo, Arnoldo, Garrè, Maria Luisa, Rossi, Andrea, Vargas, Hebert Alberto, McLoud, Theresa C., Reed, Nick, Rodriguez-Galindo, Carlos, Chandarana, Hersh, Vargas, Hebert Alberto, Francis, Isaac R., Wasnik, Ashish P., Diederich, Stefan, Fütterer, Jurgen J., Oyen, Wim J. G., Chaw, Cheng Lee, van As, Nicholas, Vieira, Igor, De Keyzer, Frederik, Dresen, Elleke, Han, Sileny, Vergote, Ignace, Moerman, Philippe, Amant, Frederic, Koole, Michel, Vandecaveye, Vincent, Dresen, R., De Vuysere, S., De Keyzer, F., Van Cutsem, E., D’Hoore, A., Wolthuis, A., Vandecaveye, V., Pricolo, P., Alessi, S., Summers, P., Tagliabue, E., Petralia, G., Pfannenberg, C., Gückel, B., Schüle, S. C., Müller, A. C., Kaufmann, S., Schwenzer, N., Reimold, M., la Fougere, C., Nikolaou, K., Martus, P., Cook, G. J., Azad, G. K., Taylor, B. P., Siddique, M., John, J., Mansi, J., Harries, M., Goh, V., Seth, S., Burgul, R., Seth, A., Waugh, S., Gowdh, N. Muhammad, Purdie, C., Evans, A., Crowe, E., Thompson, A., Vinnicombe, S., Arfeen, F., Campion, T., Goldstraw, E., D’Onofrio, M., Ciaravino, V., Crosara, S., De Robertis, R., Mucelli, R. Pozzi, Uhrig, M., Simons, D., Schlemmer, H., Downey, Kate, Murdoch, S., Al-adhami, A. S., Viswanathan, S., Smith, S., Jennings, P., Bowers, D., Soomal, R., Smith, S., Jennings, P., Bowers, D., Soomal, R., Mutala, T. M., Odhiambo, A. O., Harish, N., Pricolo, P., Alessi, S., Summers, P., Tagliabue, E., Petralia, G., Hall, M., Sproule, M., Sheridan, S., Thein, K. Y., Tan, C. H., Thian, Y. L., Ho, C. M., De Luca, S., Carrera, C., Blanchet, V., Alarcón, L., Eyheremnedy, E., Choudhury, B. K., Bujarbarua, K., Barman, G., Cook, G. J., Lovat, E., Siddique, M., Goh, V., Ferner, R., Warbey, V. S., Potti, L., Kaye, B., Beattie, A., Dutton, K., Seth, A. A., Constantinidis, F., Dobson, H., Seth, A. A., Constantinidis, F., Dobson, H., Bradley, R., Bozas, G., Avery, G., Stephens, A., Maraveyas, A., Bhuva, S., Johnson, C. A., Subesinghe, M., Taylor, N., Quint, L. E., Reddy, R. M., Kalemkerian, G. P., Zapico, G. González, Jauregui, E. Gainza, Francisco, R. Álvarez, Alonso, S. Ibáñez, Bahillo, I. Tavera, Álvarez, L. Múgica, Francies, O., Wheeler, R., Childs, L., Adams, A., Sahdev, A., De Luca, S. E., Vañek, M. E. Casalini, Pascuzzi, M. D., Gillanders, T., Ramos, P. M., Eyheremendy, E. P., Stove, C., Digby, M., Nazar, M., Wirtz, M., Pascuzzi, M. D., Troncoso, F., Saguier, F., Eyheremendy, E. P., Quint, D. J., Dang, L., Carlson, M., Leber, S., Silverstein, F., Rueben, R., Viswanathan, S., Nazir, B., Teo, T. H., Khoo, J. B., Sharma, K., Gupta, N., Mathew, B., Jeyakumar, T., Harkins, K., Sharma, K., Mathew, B., Gupta, N., Jeyakumar, T., Joshua, S., Christodoulou, D., Gourtsoyianni, S., Jacques, A., Griffin, N., Goh, V., Johnson, C. A., Lee, J., Goodfellow, J. A., Al-adhami, A. S., Viswanathan, S., Bradley, R., Bradley, R., Yong, A., Jenkins, S., Joseph, G., Bhuva, S., Partington, K., Johnson, C. A., Bhuva, S., Subesinghe, M., Taylor, N., Carrera, C., Zanfardini, A., De Luca, S., Alarcón, L., Blanchet, V., Eyheremendy, E. P., Cavanagh, K., Lau, E.
    Publicado 2016
    “…Mayerhoefer, Markus Raderer, Alexander Haug O18 Managing high-risk and advanced prostate cancer Matthias Eiber O19 Immunotherapy: imaging challenges Bernhard Gebauer O20 RECIST and RECIST 1.1 Andrea Rockall O21 Challenges of RECIST in oncology imaging basics for the trainee and novice Aslam Sohaib O22 Lymphoma: PET for interim and end of treatment response assessment: a users’ guide to the Deauville Score Victoria S Warbey O23 Available resources Hebert Alberto Vargas O24 ICIS e-portal and the online learning community Dow-Mu Koh O25 Benign lesions that mimic pancreatic cancer Jay P Heiken O26 Staging and reporting pancreatic malignancies Isaac R Francis, Mahmoud, M Al-Hawary, Ravi K Kaza O27 Intraductal papillary mucinous neoplasm Giovanni Morana O28 Cystic pancreatic tumours Mirko D’Onofrio O29 Diffusion-weighted imaging of head and neck tumours Harriet C. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course: Glasgow, UK. 3–5 October 2016
  18. 138718
    por Singh, Randhir
    Publicado 2023
    “…It also describes different effects like Cold Nuclear Matter (CNM) effects and Hot Nuclear Matter (HNM) effects that occur due the differences in the collision systems such pp, pA and AA. A summary of the results from the study of open heavy flavours in pp, pA,and AA collisions performed in different experiments like RHIC and LHC is also presented. …”
    Enlace del recurso
    Open charm studies as function of event shape variable with ALICE detector at the LHC
  19. 138719
    “…[Figure: see text] RESULTS: A summary of response for efficacy endpoints among the 172 evaluable patients with SAB is provided in Table 2. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2532. Pharmacokinetic-Pharmacodynamic Analyses for Ceftobiprole Efficacy Based on Phase 3 Data from Patients with Staphylococcus aureus Bacteremia
  20. 138720
    por Landrigan, Philip J., Raps, Hervé, Cropper, Maureen, Bald, Caroline, Brunner, Manuel, Canonizado, Elvia Maya, Charles, Dominic, Chiles, Thomas C., Donohue, Mary J., Enck, Judith, Fenichel, Patrick, Fleming, Lora E., Ferrier-Pages, Christine, Fordham, Richard, Gozt, Aleksandra, Griffin, Carly, Hahn, Mark E., Haryanto, Budi, Hixson, Richard, Ianelli, Hannah, James, Bryan D., Kumar, Pushpam, Laborde, Amalia, Law, Kara Lavender, Martin, Keith, Mu, Jenna, Mulders, Yannick, Mustapha, Adetoun, Niu, Jia, Pahl, Sabine, Park, Yongjoon, Pedrotti, Maria-Luiza, Pitt, Jordan Avery, Ruchirawat, Mathuros, Seewoo, Bhedita Jaya, Spring, Margaret, Stegeman, John J., Suk, William, Symeonides, Christos, Takada, Hideshige, Thompson, Richard C., Vicini, Andrea, Wang, Zhanyun, Whitman, Ella, Wirth, David, Wolff, Megan, Yousuf, Aroub K., Dunlop, Sarah
    Publicado 2023
    “…Biomedical research is needed to elucidate the human health impacts of plastics, especially MNPs. SUMMARY: This Commission finds that plastics are both a boon to humanity and a stealth threat to human and planetary health. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Minderoo-Monaco Commission on Plastics and Human Health
Herramientas de búsqueda: RSS